Kerry Segal, MBA

Senior Director, Business Development


Kerry Segal is Senior Director of Business and Corporate Development of Terns Pharmaceuticals. Kerry is an experienced veteran of the pharmaceutical industry, with over 30-years of relevant experience and a proven record of success in business and corporate development. Kerry’s expertise involves multiple stages of business development, including negotiations and transactions, in-licensing, out-licensing, and M&A deals. Prior to joining Terns, Kerry held leadership roles at Impax Pharma, Valeant Pharma, Cephalon, and Johnson and Johnson.

Kerry holds a B.S. in accounting and an MBA, with a major in marketing, both from Temple University.